No Data
No Data
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
These Stocks Are Expected to See at Least 25% Revenue Growth in 2025 – Wolfe
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Unpacking the Latest Options Trading Trends in Merck & Co
FDA Issues Draft Guidance on Developing Weight Loss Drugs